Matches 1 - 50 out of 53 1 2 >


Match Document Document Title
US20140227194 Preparation for Restenosis Prevention  
The invention relates to a preparation for restenosis prevention. The preparations for restenosis prevention known as yet do not reach sufficient active agent concentrations in the affected...
US20140227193 Preparation for Restenosis Prevention  
The invention relates to a preparation for restenosis prevention. The preparations for restenosis prevention known as yet do not reach sufficient active agent concentrations in the affected...
US20140227192 Preparation for Restenosis Prevention  
The invention relates to a preparation for restenosis prevention. The preparations for restenosis prevention known as yet do not reach sufficient active agent concentrations in the affected...
US20140205544 Cancer Treatment Comprising Therapeutics That Bind To Phosphatidylserine  
Disclosed is the surprising discovery that aminophospholipids, such as phosphatidylserine and phosphatidylethanolamine, are specific, accessible and stable markers of the luminal surface of tumor...
US20100310474 PROTEIN CAGES FOR THE DELIVERY OF MEDICAL IMAGING AND THERAPEUTIC AGENTS  
The present invention is directed to novel compositions and methods utilizing delivery agents comprising protein cages, medical imaging agents and therapeutic agents.
US20120087868 NANOPARTICLE-LOADED CELLS  
The invention provides nanoparticle-loaded cells and compositions useful for improved imaging and therapy, for example radio-therapy. The invention also provides methods of manufacture of...
US20080241072 INJECTABLE VOID FILLER FOR SOFT TISSUE AUGMENTATION  
The present invention teaches a micro-porous injectable, soft elastic, fully resorbable fibrin-based composition for use as a soft tissue lumen and void filler. The composition of the present...
US20090311179 Selective Targeting of Apoptotic Cells  
The invention relates to a method of selectively targeting an active agent (or agent capable of becoming an active agent) to apoptotic cells in a vertebrate, comprising administering to said...
US20130089505 SINGLE VIAL FORMULATION FOR MEDICAL GRADE CYANOACRYLATE  
Alkyl cyanoacrylate compositions and methods for making those compositions, utilizing high purity monomeric starting materials, formed into more viscous oligomers, and combined with a plasticizer...
US20080003183 Nanoparticle radiosensitizers  
Herein is described Nanostructure Enhanced X-ray Therapy (NEXT), which uses nanomaterials as radiosensitizers to enhance electromagnetic radiation absorption in specific cells or tissues. The...
US20150258219 ELECTROSTATIC-BONDING-TYPE VESICLE INCLUDING METAL MICROPARTICLES  
A vesicle comprising fine metal particles, which has a membrane formed from both a first polymer of (a) or (b) shown below and a second polymer of (c) or (d) shown below (with the proviso that a...
US20070098642 Nanoparticle-based imaging agents for X-ray/computed tomography  
The present invention is generally directed to core/shell nanoparticles, wherein such core/shell nanoparticles comprise a nanoparticle core and a nanoshell disposed about the nanoparticle core...
US20110097276 Diagnosis of Prostate Cancer  
Methods for diagnosing prostate cancer, and differentiate prostate cancer from other prostate complications, and use of said method, and diagnosing and monitoring lymph gland metastasis, post...
US20070098641 Nanoparticle-based imaging agents for X-ray/computed tomography  
The present invention is generally directed to core/shell nanoparticles, wherein such core/shell nanoparticles comprise a nanoparticle core and a nanoshell disposed about the nanoparticle core...
US20070098640 Nanoparticle-based imaging agents for X-ray/computed tomography  
The present invention is generally directed to core/shell nanoparticles, wherein such core/shell nanoparticles comprise a nanoparticle core and a nanoshell disposed about the nanoparticle core...
US20120087860 METHODS FOR IN VIVO CANCER DETECTION, DIAGNOSIS AND THERAPY USING MULTIDOMAIN BIOTAGS  
In another embodiment, a method for detecting and/or diagnosing a cancer in a subject is provided. The method may include administering an effective dose of a biotag to a subject, or...
US20070031339 Contrast agents  
The present invention relates to particles comprising cores of tungsten or tungsten in mixture with other metallic elements as the contrast enhancing material wherein said core are coated, to...
US20050008574 Use of intravenous contrast media for projection mammography  
The invention relates to the use of intravenous contrast media for projection mammography as well as new devices for projection mammography. The invention therefore relates to the use of...
US20130030282 SYNTHESIS AND CHARACTERIZATION OF NEAR IR FLUORESCENT MAGNETIC AND NON-MAGNETIC ALBUMIN NANOPARTICLES FOR BIOMEDICAL APPLICATIONS  
The present invention discloses Near Infrared (NIR) fluorescent albumin nanoparticles having a structure selected from a core structure or a core-shell structure. Also disclosed are a process of...
US20150004103 Tumorspecific PET/MR(T1), PET/MR(T2) and PET/CT contrast agent  
New types of nanoparticle-based dual-modality positron emission tomography/magnetic resonance imaging (PET/MRI) and positron emission tomography/computed tomography (PET/CT) tumorspecific contrast...
US20080003182 Shortened Carbon Nanotubes  
A shortened carbon nanotube and methods for preparing the same and contrast agents are disclosed. One embodiment includes a shortened carbon nanotube. The shortened carbon nanotube has a length of...
US20060286037 Heart-slowing drug containing short-acting ß blocker as the active ingredient  
The present invention relates to an agent which slows down the heart rate which has an excellent controlling ability in diagnostic imaging comprising a short-acting β-blocker (e.g. landiolol...
US20160136304 COMPOSITIONS AND METHODS FOR USE IN ONCOLOGY  
The present invention relates to compositions and methods for use in medical diagnostic and patient monitoring, typically in the context of therapy, in particular in the context of oncology to...
US20100111859 Visualization of Biological Material by the Use of Coated Contrast Agents  
A method for visualizing biological material, preferably by MRI, comprising the steps of: (i) bringing a population of coated nanoparticles into contact with said biological material, each of...
US20160274086 Methods compositions and kits for imaging cells and tissues using nanoparticles and spatial frequency heterodyne imaging  
Methods, compositions, systems, devices and kits are provided herein for preparing and using a nanoparticle composition and spatial frequency heterodyne imaging for visualizing cells or tissues....
US20100047181 MIXTURE OF A VANILLOID RECEPTOR AGONIST AND A SUBSTANCE INHIBITING NERVE REGENERATION, USE THEREOF FOR PRODUCING A PAINKILLER, AND METHOD FOR APPLYING SAID PAINKILLER  
The following abstract will replace all prior versions of the abstract in the application: The mixture comprises a vanilloid receptor agonist with a substance, which inhibits nerve regeneration....
US20120258051 Multistrata nanoparticles and methods for making multistrata nanoparticles  
A composition comprising a core comprising an iron oxide, a first shell comprising at least one plasmon active metal at least partially surrounding the core, a second shell comprising a dielectric...
US20100166664 NANOPARTICLE CONTRAST AGENTS FOR DIAGNOSTIC IMAGING  
Compositions of nanoparticles functionalized with at least one zwitterionic moiety, methods for making a plurality of nanoparticles, and methods of their use as diagnostic agents are provided. The...
US20150218273 ONCOFETAL ANTIGEN/IMMATURE LAMININ RECEPTOR ANTIBODIES FOR DIAGNOSTIC AND CLINICAL APPLICATIONS  
The present invention relates to antibodies against Oncofetal Antigen/immature Laminin receptor protein (OFA/iLRP) that can be used singly or in conjunction to detect or treat OFA/iLRP-related...
US20150139913 MEDICAL USE OF PARTICLES OF TITANIUM AND/OR TITANIUM OXIDE  
The present invention describes particles of titanium, titanium alloy, at least one type of titanium oxide or a combination thereof, wherein at least a substantial amount of the particles are of...
US20110064676 Diagnostic and therapeutic nanoparticles  
The present invention relates to diagnostic and therapeutic nanoparticles. More particularly, the present invention relates to creating a hybrid gold/gold sulfide nanoparticle with a chitosan...
US20130129632 Quantum dot materials, methods for making them, and uses thereof  
The disclosure provides quantum dot materials, compositions and methods useful in the treatment of various disorders. In particular, the disclosure provides cadmium-free and lead-free quantum dots.
US20150173847 IMAGING MARKER AND UTILIZATION THEREOF  
As an imaging marker for generating suitable contrasts in images taken through a plurality of medical diagnostic imaging techniques, a liquid containing a transition metal belonging to any of the...
US20150362500 X-ray Excited Optical Materials and Methods for High Resolution Chemical Imaging  
X-ray/optical imaging materials are described and techniques as may be used for sensitive and high spatial resolution chemical and biophysical imaging in tissue. The technique uses high spatial...
US20160220734 PHOTO-ACTIVE AND RADIO-OPAQUE SHAPE MEMORY POLYMER-GOLD NANOCOMPOSITE MATERIALS FOR TRANS-CATHETER MEDICAL DEVICES  
There is disclosed a trans-catheter cardiovascular device, comprising a composite material having gold nanoparticles embedded in a shape memory polymer. In an embodiment, the gold nanoparticles...
US20100284936 CONTRAST AGENTS  
The present invention relates to liposomes comprising particles with cores of tungsten or tungsten in mixture with other metallic elements as the contrast enhancing material and to the use of such...
US20060120965 Trimeric, macrocyclically substituted aminoisophthalic acid-halo-benzene derivatives  
The metal complexes of general formula I in which Hal stands for bromine or iodine, and A1 and A2 have different meanings, are suitable as contrast media.
US20100191096 PARAMAGNETIC BIOMOLECULE COMPLEXES AND USES THEREOF IN THE ASSESSMENT OF ORGAN FUNCTION  
The present invention relates to complexes comprising one or more marker(s) and one or more biomolecules. The complexes according to the present invention have a variety of utilities, such as...
US20150037250 CONTRAST AGENT  
According to one embodiment, a contrast agent includes a blood vessel contrast enhancement particles configured to enhance contrast of a blood vessel of an object and a diseased tissue contrast...
US20090098047 BIOCONJUGATES OF METAL COMPLEXES OF NITROGEN-CONTAINING MACROCYCLIC LIGANDS  
The present invention is directed to bioconjugates of complexes represented by the formula: wherein R, R′, R1, R′1, R2, R′2, R3, R′3, R4, R′4, R5, R′5, R6, R′6, R7, R′7, R8, R′8, R9, R′9, M, X, Y,...
US20160271251 RADIOLUMINESCENT COMPOUND FOR RADIOTHERAPY AND DEEP PHOTODYNAMIC THERAPY AND DEVICE FOR DEEP PHOTODYNAMIC THERAPY  
A radioluminescent compound for radiotherapy and deep photodynamic therapy (Deep PDT), the radioluminescent compound including a molecular conjugate made up of a radioluminescent molecule and one...
US20070116647 Medicinal preparation particularly for the treatment of slipped discs hernias  
The invention concerns a product consisting in an injection medicinal formulations comprising at least one compound to provide a viscous formulation, ethanol and at least one compound making said...
US20130017155 DUAL CT/MRI NANOPARTICLE CONTRAST AGENT  
The invention relates to a new tungsten-iron-Ferritin nanoparticle and uses thereof in imaging.
US20050238583 Contrast agent specifically suitable for X-ray computed tomography  
A contrast agent for medical imaging has a component in the form of a chemical compound of gadolinium that is effective for x-ray computed tomography, that has at least one additive that prevents...
US20100278749 NANOPARTICLE CONTRAST AGENTS FOR DIAGNOSTIC IMAGING  
Compositions of nanoparticles functionalized with at least one net positively charged group and at least one net negatively charged group, methods for making a plurality of nanoparticles, and...
US20120148501 RADIOLOGICAL IMAGE ENHANCEMENT WITH TANTALUM CLUSTERS  
A solution comprising a defined concentration of purified tantalum clusters in a solvent selected from the group consisting of water, ethanol, ethylene glycol and propylene glycol; wherein said...
US20160060209 BIS AZAINOSITOL HAFNIUM COMPLEXES FOR X-RAY IMAGING  
The present invention describes a new class of trinuclear hafnium complexes comprising two hexadentate azainositol carboxylic acid ligands, methods for their preparation and their use as X-ray...
US20150132229 BIS AZAINOSITOL HEAVY METAL COMPLEXES FOR X-RAY IMAGING  
The present invention describes a new class of trinuclear heavy metal complexes comprising two hexadentate azainositol tricarboxylic acid ligands, a method for their preparation and their use as...
US20080233052 Contrast Agents  
The present invention relates to particles comprising cores of tungsten or tungsten in mixture with other metallic elements wherein said cores are coated and have an average size of at least 20...
US20060034768 Method and device for molecular imaging with the aid of molecular probe  
A method is disclosed for molecular imaging with the aid of a molecular probe, the latter containing a contrast enhancing component that is detectable via X-ray fluorescence radiation emitted...

Matches 1 - 50 out of 53 1 2 >